About ThunderBio Innovation
ThunderBio Innovation is a Healthcare company based in Jiaxing (China) founded in 2018 by Joseph Chow. Microfluidic technology is developed for diagnostic and research applications. ThunderBio Innovation has raised $15.47 million across 3 funding rounds from investors including Luxin Venture Capital, Zhuopu Investment and Guangzhou Financial Holdings. Its chief executive, as recorded, is Joseph Chow. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Diversified.
Company details
ThunderBio Innovation was founded in 2018 in Jiaxing, China, focusing on microfluidic technologies within the biotechnology sector. Operations center on the creation of lab-on-a-chip systems for digital liquid biopsy, alongside instruments such as digital PCR devices, biochip analyzers, droplet generators, and constant pressure pumps. Reagent kits, including those for digital PCR, nucleic acid extraction, and thermostatic amplification, are also produced to support diagnostic and research workflows.
- Headquarters Jiaxing, China
- Founders Joseph Chow
- SectorsHealthcare
- Phone•••• ••••
- Website thunder-bio.com
- Total Equity Funding$15.47M (USD)
in 3 rounds
- Latest Funding Round$14.06M (USD), Series B
Jan 2024
- InvestorsLuxin Venture Capital
& 9 more
Funding Insights of ThunderBio Innovation
ThunderBio Innovation has successfully raised a total of $15.47M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $14.06 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.47M
- Total Rounds 3
- Last Round Series B — $14.06M
- First Round $1.41M
(Mar 2020)
- Investors Count 10
All 3 funding rounds of ThunderBio Innovation with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $14.06M | Series B | – | Luxin Venture Capital, Zhuopu Investment | |
| Aug 2021 | Series A | – | – | ||
| Mar 2020 | $1.41M | Seed | – | – | – |
10 investors in total: 10 institutional.
Investors in ThunderBio Innovation
ThunderBio Innovation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Luxin Venture Capital, Zhuopu Investment and Guangzhou Financial Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Bridgeone Capital is engaged in venture capital investments. | bridgeonecap.com | |||
| theguangzhoujinkong.tcc.mode | ||||
| dtcap.com | ||||
| luxinventurecapital.tcc.mode | ||||
| zhuopuinvestment.tcc.mode | ||||
| guangzhoufinancialholdings.tcc.mode | ||||
| daohetechnologyinvestment.tcc.mode | ||||
| shenzhenchenmuyuntechnology.tcc.mode | ||||
| shanghaisimpleinvestmentcenter.tcc.mode | ||||
| bftfund.com |
Investor details for ThunderBio Innovation
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ThunderBio Innovation
1 people are tracked at ThunderBio Innovation (1 in leadership).
| Name | Role | Group |
|---|---|---|
Joseph Chow | Co-Founder & CEO | Leadership |
Complete people profiles for ThunderBio Innovation
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ThunderBio Innovation
3 dated milestones of ThunderBio Innovation across 6 years, from founding to its latest funding, stage changes and deals.
- Founded ThunderBio Innovation is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Series B, of $14.1M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Thunderbio Innovation
Complete news archive for ThunderBio Innovation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThunderBio Innovation
ThunderBio Innovation was founded in 2018 and raised its 1st funding round 2 years after it was founded.
ThunderBio Innovation is headquartered in Jiaxing, China. It is registered at Jiaxing, Zhejiang, China.
Joseph Chow is the CEO of ThunderBio Innovation, as recorded in our data. They have also founded this company.
ThunderBio Innovation is a funded company, having raised a total of $15.47M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.41M, raised on Mar 2020.
ThunderBio Innovation was founded in 2018 in Jiaxing, China, focusing on microfluidic technologies within the biotechnology sector. Operations center on the creation of lab-on-a-chip systems for digital liquid biopsy, alongside instruments such as digital PCR devices, biochip analyzers, droplet generators, and constant pressure pumps. Reagent kits, including those for digital PCR, nucleic acid extraction, and thermostatic amplification, are also produced to support diagnostic and research workflows.
ThunderBio Innovation has 10 investors. Key investors include Luxin Venture Capital, Zhuopu Investment, Guangzhou Financial Holdings, Daohe Technology Investment, and Shenzhen Chenmuyun Technology.